India's cheap weight-loss drugs could reshape global obesity fight
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Similar Stories
Related coverage based on topic and tags
Indian billionaires buy foreign companies as growth slows at home
India Inc spent $18bn on global buyouts in 2025 and the deal value could cross $15bn in the first half of 2026.
May 24, 2026 at 11:01 PMAI may speed up search for drugs to treat brain conditions
Researchers hope the work will help identify affordable, effective drugs to treat conditions like MND.
May 22, 2026 at 09:30 PMIndia regulator cracks down on seven in social media stock manipulation case - Reuters
India regulator cracks down on seven in social media stock manipulation case Reuters
May 22, 2026 at 07:43 PMZuckerberg's philanthropic venture unveils AI world model for drug discovery - Reuters
Zuckerberg's philanthropic venture unveils AI world model for drug discovery Reuters
May 27, 2026 at 02:59 PMIntel, 3DGS to set up $3.3 billion substrate plant in India's Odisha state - Reuters
Intel, 3DGS to set up $3.3 billion substrate plant in India's Odisha state Reuters
May 29, 2026 at 12:48 PMIndian finance minister calls for focus on '3Fs' – fuel, fertiliser, forex - Reuters
Indian finance minister calls for focus on '3Fs' – fuel, fertiliser, forex Reuters
May 25, 2026 at 07:56 AM